PVI
PRCT icon

Pura Vida Investments’s Procept Biorobotics PRCT Stock Holding History

Pura Vida Investments’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-155,214
Closed -$3.88M – 276
2021
Q4 		$3.88M Sell
155,214
-4,786
-3% -$177K 0.14% 123
2021
Q3 		$6.1M Buy
+160,000
New +$6.14M 0.19% 133

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Pura Vida Investments's PRCT Position: Q1 2022 in Review

Pura Vida Investments sold out of Procept Biorobotics (PRCT) in Q1 2022, closing a stake of 155,214 shares — an estimated $3.88M sold.

Pura Vida Investments first reported a position in PRCT in Q3 2021 and held it in 2 quarters. The position peaked at $6.1M in Q3 2021. 58 funds tracked by Wall St. Rank hold PRCT as of Q1 2022.

  • Pura Vida Investments reported no remaining Procept Biorobotics position as of Q1 2022 after selling out during the quarter.
  • Pura Vida Investments sold 155,214 Procept Biorobotics shares in Q1 2022, an estimated $3.88M.
  • Pura Vida Investments first reported a position in Procept Biorobotics in Q3 2021 and held it in 2 quarters.
  • Pura Vida Investments's Procept Biorobotics position peaked at $6.1M in Q3 2021.
  • 58 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.